| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NRX Pharmaceuticals, Inc. | General Counsel & Secretary | Common Stock | 31,584 | $10,104 | $0.3199 | 02 Sep 2021 | Direct |
| NRX Pharmaceuticals, Inc. | General Counsel & Secretary | Employee Stock Option (Right to buy) | 28,934 | $5,787 | $0.2000 | 02 Sep 2021 | Direct |
| NRX Pharmaceuticals, Inc. | General Counsel & Secretary | Restricted Stock Units | 33,603 | 02 Sep 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | 19 Aug 2021 | 10 | -$545,165 | 4 | General Counsel & Secretary | 02 Nov 2021, 16:05 |
| NRXP | NRX Pharmaceuticals, Inc. | 24 May 2021 | 4 | $0 | 4 | General Counsel & Secretary | 10 Jun 2021, 18:45 |
| NRXP | NRX Pharmaceuticals, Inc. | 24 May 2021 | 0 | $0 | 3 | General Counsel & Secretary | 10 Jun 2021, 18:30 |